Global and Japan Biologic Drugs Market Insights, Forecast to 2026

Global and Japan Biologic Drugs Market Insights, Forecast to 2026

Table of Contents
1 Study Coverage
1.1 Biologic Drugs Product Introduction
1.2 Market Segments
1.3 Key Biologic Drugs Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Biologic Drugs Market Size Growth Rate by Type
1.4.2 Humira
1.4.3 Remicade
1.4.4 Rituxan
1.4.5 Enbrel
1.4.6 Lantus
1.4.7 Avastin
1.4.8 Herceptin
1.4.9 Others
1.5 Market by Application
1.5.1 Global Biologic Drugs Market Size Growth Rate by Application
1.5.2 Diabetes
1.5.3 Inflammation
1.5.4 Auto-Immune Diseases
1.5.5 Blood Diseases
1.5.6 Cardiovascular Diseases
1.5.7 Others
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Biologic Drugs Market Size, Estimates and Forecasts
2.1.1 Global Biologic Drugs Revenue 2015-2026
2.1.2 Global Biologic Drugs Sales 2015-2026
2.2 Global Biologic Drugs, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.3 Biologic Drugs Historical Market Size by Region (2015-2020)
2.3.1 Global Biologic Drugs Retrospective Market Scenario in Sales by Region: 2015-2020
2.3.2 Global Biologic Drugs Retrospective Market Scenario in Revenue by Region: 2015-2020
2.4 Biologic Drugs Market Estimates and Projections by Region (2021-2026)
2.4.1 Global Biologic Drugs Sales Forecast by Region (2021-2026)
2.4.2 Global Biologic Drugs Revenue Forecast by Region (2021-2026)
3 Global Biologic Drugs Competitor Landscape by Players
3.1 Global Top Biologic Drugs Sales by Manufacturers
3.1.1 Global Biologic Drugs Sales by Manufacturers (2015-2020)
3.1.2 Global Biologic Drugs Sales Market Share by Manufacturers (2015-2020)
3.2 Global Biologic Drugs Manufacturers by Revenue
3.2.1 Global Biologic Drugs Revenue by Manufacturers (2015-2020)
3.2.2 Global Biologic Drugs Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Biologic Drugs Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Biologic Drugs Revenue in 2019
3.2.5 Global Biologic Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Global Biologic Drugs Price by Manufacturers
3.4 Global Biologic Drugs Manufacturing Base Distribution, Product Types
3.4.1 Biologic Drugs Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Biologic Drugs Product Type
3.4.3 Date of International Manufacturers Enter into Biologic Drugs Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Biologic Drugs Market Size by Type (2015-2020)
4.1.1 Global Biologic Drugs Sales by Type (2015-2020)
4.1.2 Global Biologic Drugs Revenue by Type (2015-2020)
4.1.3 Biologic Drugs Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Biologic Drugs Market Size Forecast by Type (2021-2026)
4.2.1 Global Biologic Drugs Sales Forecast by Type (2021-2026)
4.2.2 Global Biologic Drugs Revenue Forecast by Type (2021-2026)
4.2.3 Biologic Drugs Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Biologic Drugs Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Biologic Drugs Market Size by Application (2015-2020)
5.1.1 Global Biologic Drugs Sales by Application (2015-2020)
5.1.2 Global Biologic Drugs Revenue by Application (2015-2020)
5.1.3 Biologic Drugs Price by Application (2015-2020)
5.2 Biologic Drugs Market Size Forecast by Application (2021-2026)
5.2.1 Global Biologic Drugs Sales Forecast by Application (2021-2026)
5.2.2 Global Biologic Drugs Revenue Forecast by Application (2021-2026)
5.2.3 Global Biologic Drugs Price Forecast by Application (2021-2026)
6 Japan by Players, Type and Application
6.1 Japan Biologic Drugs Market Size YoY Growth 2015-2026
6.1.1 Japan Biologic Drugs Sales YoY Growth 2015-2026
6.1.2 Japan Biologic Drugs Revenue YoY Growth 2015-2026
6.1.3 Japan Biologic Drugs Market Share in Global Market 2015-2026
6.2 Japan Biologic Drugs Market Size by Players (International and Local Players)
6.2.1 Japan Top Biologic Drugs Players by Sales (2015-2020)
6.2.2 Japan Top Biologic Drugs Players by Revenue (2015-2020)
6.3 Japan Biologic Drugs Historic Market Review by Type (2015-2020)
6.3.1 Japan Biologic Drugs Sales Market Share by Type (2015-2020)
6.3.2 Japan Biologic Drugs Revenue Market Share by Type (2015-2020)
6.3.3 Japan Biologic Drugs Price by Type (2015-2020)
6.4 Japan Biologic Drugs Market Estimates and Forecasts by Type (2021-2026)
6.4.1 Japan Biologic Drugs Sales Forecast by Type (2021-2026)
6.4.2 Japan Biologic Drugs Revenue Forecast by Type (2021-2026)
6.4.3 Japan Biologic Drugs Price Forecast by Type (2021-2026)
6.5 Japan Biologic Drugs Historic Market Review by Application (2015-2020)
6.5.1 Japan Biologic Drugs Sales Market Share by Application (2015-2020)
6.5.2 Japan Biologic Drugs Revenue Market Share by Application (2015-2020)
6.5.3 Japan Biologic Drugs Price by Application (2015-2020)
6.6 Japan Biologic Drugs Market Estimates and Forecasts by Application (2021-2026)
6.6.1 Japan Biologic Drugs Sales Forecast by Application (2021-2026)
6.6.2 Japan Biologic Drugs Revenue Forecast by Application (2021-2026)
6.6.3 Japan Biologic Drugs Price Forecast by Application (2021-2026)
7 North America
7.1 North America Biologic Drugs Market Size YoY Growth 2015-2026
7.2 North America Biologic Drugs Market Facts & Figures by Country
7.2.1 North America Biologic Drugs Sales by Country (2015-2020)
7.2.2 North America Biologic Drugs Revenue by Country (2015-2020)
7.2.3 U.S.
7.2.4 Canada
8 Europe
8.1 Europe Biologic Drugs Market Size YoY Growth 2015-2026
8.2 Europe Biologic Drugs Market Facts & Figures by Country
8.2.1 Europe Biologic Drugs Sales by Country
8.2.2 Europe Biologic Drugs Revenue by Country
8.2.3 Germany
8.2.4 France
8.2.5 U.K.
8.2.6 Italy
8.2.7 Russia
9 Asia Pacific
9.1 Asia Pacific Biologic Drugs Market Size YoY Growth 2015-2026
9.2 Asia Pacific Biologic Drugs Market Facts & Figures by Country
9.2.1 Asia Pacific Biologic Drugs Sales by Region (2015-2020)
9.2.2 Asia Pacific Biologic Drugs Revenue by Region
9.2.3 China
9.2.4 Japan
9.2.5 South Korea
9.2.6 India
9.2.7 Australia
9.2.8 Taiwan
9.2.9 Indonesia
9.2.10 Thailand
9.2.11 Malaysia
9.2.12 Philippines
9.2.13 Vietnam
10 Latin America
10.1 Latin America Biologic Drugs Market Size YoY Growth 2015-2026
10.2 Latin America Biologic Drugs Market Facts & Figures by Country
10.2.1 Latin America Biologic Drugs Sales by Country
10.2.2 Latin America Biologic Drugs Revenue by Country
10.2.3 Mexico
10.2.4 Brazil
10.2.5 Argentina
11 Middle East and Africa
11.1 Middle East and Africa Biologic Drugs Market Size YoY Growth 2015-2026
11.2 Middle East and Africa Biologic Drugs Market Facts & Figures by Country
11.2.1 Middle East and Africa Biologic Drugs Sales by Country
11.2.2 Middle East and Africa Biologic Drugs Revenue by Country
11.2.3 Turkey
11.2.4 Saudi Arabia
11.2.5 U.A.E
12 Company Profiles
12.1 Roche
12.1.1 Roche Corporation Information
12.1.2 Roche Description and Business Overview
12.1.3 Roche Sales, Revenue and Gross Margin (2015-2020)
12.1.4 Roche Biologic Drugs Products Offered
12.1.5 Roche Recent Development
12.2 Abbott Laboratories
12.2.1 Abbott Laboratories Corporation Information
12.2.2 Abbott Laboratories Description and Business Overview
12.2.3 Abbott Laboratories Sales, Revenue and Gross Margin (2015-2020)
12.2.4 Abbott Laboratories Biologic Drugs Products Offered
12.2.5 Abbott Laboratories Recent Development
12.3 Johnson & Johnson
12.3.1 Johnson & Johnson Corporation Information
12.3.2 Johnson & Johnson Description and Business Overview
12.3.3 Johnson & Johnson Sales, Revenue and Gross Margin (2015-2020)
12.3.4 Johnson & Johnson Biologic Drugs Products Offered
12.3.5 Johnson & Johnson Recent Development
12.4 Merck & Co.
12.4.1 Merck & Co. Corporation Information
12.4.2 Merck & Co. Description and Business Overview
12.4.3 Merck & Co. Sales, Revenue and Gross Margin (2015-2020)
12.4.4 Merck & Co. Biologic Drugs Products Offered
12.4.5 Merck & Co. Recent Development
12.5 Pfizer
12.5.1 Pfizer Corporation Information
12.5.2 Pfizer Description and Business Overview
12.5.3 Pfizer Sales, Revenue and Gross Margin (2015-2020)
12.5.4 Pfizer Biologic Drugs Products Offered
12.5.5 Pfizer Recent Development
12.6 Amgen
12.6.1 Amgen Corporation Information
12.6.2 Amgen Description and Business Overview
12.6.3 Amgen Sales, Revenue and Gross Margin (2015-2020)
12.6.4 Amgen Biologic Drugs Products Offered
12.6.5 Amgen Recent Development
12.7 Sanofi
12.7.1 Sanofi Corporation Information
12.7.2 Sanofi Description and Business Overview
12.7.3 Sanofi Sales, Revenue and Gross Margin (2015-2020)
12.7.4 Sanofi Biologic Drugs Products Offered
12.7.5 Sanofi Recent Development
12.8 Novartis
12.8.1 Novartis Corporation Information
12.8.2 Novartis Description and Business Overview
12.8.3 Novartis Sales, Revenue and Gross Margin (2015-2020)
12.8.4 Novartis Biologic Drugs Products Offered
12.8.5 Novartis Recent Development
12.9 Eli Lilly
12.9.1 Eli Lilly Corporation Information
12.9.2 Eli Lilly Description and Business Overview
12.9.3 Eli Lilly Sales, Revenue and Gross Margin (2015-2020)
12.9.4 Eli Lilly Biologic Drugs Products Offered
12.9.5 Eli Lilly Recent Development
12.10 Amgen
12.10.1 Amgen Corporation Information
12.10.2 Amgen Description and Business Overview
12.10.3 Amgen Sales, Revenue and Gross Margin (2015-2020)
12.10.4 Amgen Biologic Drugs Products Offered
12.10.5 Amgen Recent Development
12.11 Roche
12.11.1 Roche Corporation Information
12.11.2 Roche Description and Business Overview
12.11.3 Roche Sales, Revenue and Gross Margin (2015-2020)
12.11.4 Roche Biologic Drugs Products Offered
12.11.5 Roche Recent Development
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter's Five Forces Analysis
13.5 Primary Interviews with Key Biologic Drugs Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Biologic Drugs Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
List of Tables
Table 1. Biologic Drugs Market Segments
Table 2. Ranking of Global Top Biologic Drugs Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Biologic Drugs Market Size Growth Rate by Type 2020-2026 (K Units) & (US$ Million)
Table 4. Major Manufacturers of Humira
Table 5. Major Manufacturers of Remicade
Table 6. Major Manufacturers of Rituxan
Table 7. Major Manufacturers of Enbrel
Table 8. Major Manufacturers of Lantus
Table 9. Major Manufacturers of Avastin
Table 10. Major Manufacturers of Herceptin
Table 11. Major Manufacturers of Others
Table 12. Global Biologic Drugs Market Size Growth Rate by Application 2020-2026 (K Units)
Table 13. Global Biologic Drugs Market Size by Region (K Units) & (US$ Million): 2020 VS 2026
Table 14. Global Biologic Drugs Sales by Regions 2015-2020 (K Units)
Table 15. Global Biologic Drugs Sales Market Share by Regions (2015-2020)
Table 16. Global Biologic Drugs Revenue by Regions 2015-2020 (US$ Million)
Table 17. Global Biologic Drugs Sales Forecast by Region (2021-2026) (K Units)
Table 18. Global Biologic Drugs Sales by Manufacturers (2015-2020) (K Units)
Table 19. Global Biologic Drugs Sales Share by Manufacturers (2015-2020)
Table 20. Global Biologic Drugs Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 21. Global Biologic Drugs by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Biologic Drugs as of 2019)
Table 22. Biologic Drugs Revenue by Manufacturers (2015-2020) (US$ Million)
Table 23. Biologic Drugs Revenue Share by Manufacturers (2015-2020)
Table 24. Key Manufacturers Biologic Drugs Price (2015-2020) (USD/Unit)
Table 25. Biologic Drugs Manufacturers Manufacturing Base Distribution and Headquarters
Table 26. Manufacturers Biologic Drugs Product Type
Table 27. Date of International Manufacturers Enter into Biologic Drugs Market
Table 28. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 29. Global Biologic Drugs Sales by Type (2015-2020) (K Units)
Table 30. Global Biologic Drugs Sales Share by Type (2015-2020)
Table 31. Global Biologic Drugs Revenue by Type (2015-2020) (US$ Million)
Table 32. Global Biologic Drugs Revenue Share by Type (2015-2020)
Table 33. Biologic Drugs Average Selling Price (ASP) by Type 2015-2020 (USD/Unit)
Table 34. Global Biologic Drugs Sales Share by Type (2021-2026)
Table 35. Global Biologic Drugs Sales by Application (2015-2020) (K Units)
Table 36. Global Biologic Drugs Sales Share by Application (2015-2020)
Table 37. Global Biologic Drugs Sales Share by Application (2021-2026)
Table 38. Global Biologic Drugs Sales Market Share Forecast by Application (2021-2026)
Table 39. Global Biologic Drugs Revenue by Application (2015-2020) (US$ Million)
Table 40. Global Biologic Drugs Revenue Market Share Forecast by Application (2021-2026)
Table 41. Japan Biologic Drugs Sales (K Units) of Key Companies (2015-2020)
Table 42. Japan Biologic Drugs Sales Share by Company (2015-2020)
Table 43. Japan Biologic Drugs Revenue (US$ Million) by Company (2015-2020)
Table 44. Japan Biologic Drugs Sales (K Units) by Type (2015-2020)
Table 45. Japan Biologic Drugs Sales Share by Type (2015-2020)
Table 46. Japan Biologic Drugs Revenue (US$ Million) Market Share by Type (2015-2020)
Table 47. Japan Biologic Drugs Price (K Units) by Type (2015-2020)
Table 48. Japan Biologic Drugs Sales (K Units) by Type (2021-2026)
Table 49. Japan Biologic Drugs Sales Share by Type (2021-2026)
Table 50. Japan Biologic Drugs Revenue (US$ Million) Market Share by Type (2021-2026)
Table 51. Japan Biologic Drugs Revenue Share by Type (2021-2026)
Table 52. Japan Biologic Drugs Price (K Units) by Type (2021-2026)
Table 53. Japan Biologic Drugs Sales (K Units) by Application (2015-2020)
Table 54. Japan Biologic Drugs Sales Share by Application (2015-2020)
Table 55. Japan Biologic Drugs Revenue (US$ Million) Market Share by Application (2015-2020)
Table 56. Japan Biologic Drugs Sales (K Units) by Application (2021-2026)
Table 57. Japan Biologic Drugs Sales Share by Application (2021-2026)
Table 58. Japan Biologic Drugs Revenue (US$ Million) Market Share by Application (2021-2026)
Table 59. Japan Biologic Drugs Revenue Share by Application (2021-2026)
Table 60. North America Biologic Drugs Sales by Country (2015-2020) (K Units)
Table 61. North America Biologic Drugs Sales Market Share by Country (2015-2020)
Table 62. North America Biologic Drugs Revenue by Country (2015-2020) (US$ Million)
Table 63. North America Biologic Drugs Revenue Market Share by Country (2015-2020)
Table 64. Europe Biologic Drugs Sales by Country (2015-2020) (K Units)
Table 65. Europe Biologic Drugs Sales Market Share by Country (2015-2020)
Table 66. Europe Biologic Drugs Revenue by Country (2015-2020) (US$ Million)
Table 67. Europe Biologic Drugs Revenue Market Share by Country (2015-2020)
Table 68. Asia Pacific Biologic Drugs Sales by Region (2015-2020) (K Units)
Table 69. Asia Pacific Biologic Drugs Sales Market Share by Region (2015-2020)
Table 70. Asia Pacific Biologic Drugs Revenue by Region (2015-2020) (US$ Million)
Table 71. Asia Pacific Biologic Drugs Revenue Market Share by Region (2015-2020)
Table 72. Latin America Biologic Drugs Sales by Country (2015-2020) (K Units)
Table 73. Latin America Biologic Drugs Sales Market Share by Country (2015-2020)
Table 74. Latin Americaa Biologic Drugs Revenue by Country (2015-2020) (US$ Million)
Table 75. Latin America Biologic Drugs Revenue Market Share by Country (2015-2020)
Table 76. Middle East and Africa Biologic Drugs Sales by Country (2015-2020) (K Units)
Table 77. Middle East and Africa Biologic Drugs Sales Market Share by Country (2015-2020)
Table 78. Middle East and Africa Biologic Drugs Revenue by Country (2015-2020) (US$ Million)
Table 79. Middle East and Africa Biologic Drugs Revenue Market Share by Country (2015-2020)
Table 80. Roche Corporation Information
Table 81. Roche Description and Business Overview
Table 82. Roche Biologic Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 83. Roche Biologic Drugs Product
Table 84. Roche Recent Development
Table 85. Abbott Laboratories Corporation Information
Table 86. Abbott Laboratories Description and Business Overview
Table 87. Abbott Laboratories Biologic Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 88. Abbott Laboratories Product
Table 89. Abbott Laboratories Recent Development
Table 90. Johnson & Johnson Corporation Information
Table 91. Johnson & Johnson Description and Business Overview
Table 92. Johnson & Johnson Biologic Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 93. Johnson & Johnson Product
Table 94. Johnson & Johnson Recent Development
Table 95. Merck & Co. Corporation Information
Table 96. Merck & Co. Description and Business Overview
Table 97. Merck & Co. Biologic Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 98. Merck & Co. Product
Table 99. Merck & Co. Recent Development
Table 100. Pfizer Corporation Information
Table 101. Pfizer Description and Business Overview
Table 102. Pfizer Biologic Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 103. Pfizer Product
Table 104. Pfizer Recent Development
Table 105. Amgen Corporation Information
Table 106. Amgen Description and Business Overview
Table 107. Amgen Biologic Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 108. Amgen Product
Table 109. Amgen Recent Development
Table 110. Sanofi Corporation Information
Table 111. Sanofi Description and Business Overview
Table 112. Sanofi Biologic Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 113. Sanofi Product
Table 114. Sanofi Recent Development
Table 115. Novartis Corporation Information
Table 116. Novartis Description and Business Overview
Table 117. Novartis Biologic Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 118. Novartis Product
Table 119. Novartis Recent Development
Table 120. Eli Lilly Corporation Information
Table 121. Eli Lilly Description and Business Overview
Table 122. Eli Lilly Biologic Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 123. Eli Lilly Product
Table 124. Eli Lilly Recent Development
Table 125. Amgen Corporation Information
Table 126. Amgen Description and Business Overview
Table 127. Amgen Biologic Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 128. Amgen Product
Table 129. Amgen Recent Development
Table 130. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 131. Key Challenges
Table 132. Market Risks
Table 133. Main Points Interviewed from Key Biologic Drugs Players
Table 134. Biologic Drugs Customers List
Table 135. Biologic Drugs Distributors List
Table 136. Research Programs/Design for This Report
Table 137. Key Data Information from Secondary Sources
Table 138. Key Data Information from Primary Sources
List of Figures
Figure 1. Biologic Drugs Product Picture
Figure 2. Global Biologic Drugs Sales Market Share by Type in 2020 & 2026
Figure 3. Humira Product Picture
Figure 4. Remicade Product Picture
Figure 5. Rituxan Product Picture
Figure 6. Enbrel Product Picture
Figure 7. Lantus Product Picture
Figure 8. Avastin Product Picture
Figure 9. Herceptin Product Picture
Figure 10. Others Product Picture
Figure 11. Global Biologic Drugs Sales Market Share by Application in 2020 & 2026
Figure 12. Diabetes
Figure 13. Inflammation
Figure 14. Auto-Immune Diseases
Figure 15. Blood Diseases
Figure 16. Cardiovascular Diseases
Figure 17. Others
Figure 18. Biologic Drugs Report Years Considered
Figure 19. Global Biologic Drugs Market Size 2015-2026 (US$ Million)
Figure 20. Global Biologic Drugs Sales 2015-2026 (K Units)
Figure 21. Global Biologic Drugs Market Size Market Share by Region: 2020 Versus 2026
Figure 22. Global Biologic Drugs Sales Market Share by Region (2015-2020)
Figure 23. Global Biologic Drugs Sales Market Share by Region in 2019
Figure 24. Global Biologic Drugs Revenue Market Share by Region (2015-2020)
Figure 25. Global Biologic Drugs Revenue Market Share by Region in 2019
Figure 26. Global Biologic Drugs Sales Share by Manufacturer in 2019
Figure 27. The Top 10 and 5 Players Market Share by Biologic Drugs Revenue in 2019
Figure 28. Biologic Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 29. Global Biologic Drugs Sales Market Share by Type (2015-2020)
Figure 30. Global Biologic Drugs Sales Market Share by Type in 2019
Figure 31. Global Biologic Drugs Revenue Market Share by Type (2015-2020)
Figure 32. Global Biologic Drugs Revenue Market Share by Type in 2019
Figure 33. Global Biologic Drugs Market Share by Price Range (2015-2020)
Figure 34. Global Biologic Drugs Sales Market Share by Application (2015-2020)
Figure 35. Global Biologic Drugs Sales Market Share by Application in 2019
Figure 36. Global Biologic Drugs Revenue Market Share by Application (2015-2020)
Figure 37. Global Biologic Drugs Revenue Market Share by Application in 2019
Figure 38. Japan Biologic Drugs Sales Growth Rate 2015-2026 (K Units)
Figure 39. Japan Biologic Drugs Revenue Growth Rate 2015-2026 (US$ Million)
Figure 40. Japan Biologic Drugs Market Share in Global Market 2015-2026
Figure 41. Japan 5 and 10 Largest Biologic Drugs Players Market Share by Revenue in Biologic Drugs in 2019
Figure 42. Japan Biologic Drugs Revenue Share by Type (2015-2020)
Figure 43. Japan Biologic Drugs Revenue Growth Rate by Type in 2015 & 2019
Figure 44. Japan Biologic Drugs Revenue Share by Application (2015-2020)
Figure 45. Japan Biologic Drugs Revenue Growth Rate by Application in 2015 & 2019
Figure 46. North America Biologic Drugs Sales Growth Rate 2015-2020 (K Units)
Figure 47. North America Biologic Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 48. North America Biologic Drugs Sales Market Share by Country in 2019
Figure 49. North America Biologic Drugs Revenue Market Share by Country in 2019
Figure 50. U.S. Biologic Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 51. U.S. Biologic Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. Canada Biologic Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 53. Canada Biologic Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 54. Europe Biologic Drugs Sales Growth Rate 2015-2020 (K Units)
Figure 55. Europe Biologic Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 56. Europe Biologic Drugs Sales Market Share by Country in 2019
Figure 57. Europe Biologic Drugs Revenue Market Share by Country in 2019
Figure 58. Germany Biologic Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 59. Germany Biologic Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 60. France Biologic Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 61. France Biologic Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 62. U.K. Biologic Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 63. U.K. Biologic Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 64. Italy Biologic Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 65. Italy Biologic Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 66. Russia Biologic Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 67. Russia Biologic Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 68. Asia Pacific Biologic Drugs Sales Growth Rate 2015-2020 (K Units)
Figure 69. Asia Pacific Biologic Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 70. Asia Pacific Biologic Drugs Sales Market Share by Region in 2019
Figure 71. Asia Pacific Biologic Drugs Revenue Market Share by Region in 2019
Figure 72. China Biologic Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 73. China Biologic Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 74. Japan Biologic Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 75. Japan Biologic Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. South Korea Biologic Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 77. South Korea Biologic Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. India Biologic Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 79. India Biologic Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 80. Australia Biologic Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 81. Australia Biologic Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 82. Taiwan Biologic Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 83. Taiwan Biologic Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 84. Indonesia Biologic Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 85. Indonesia Biologic Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 86. Thailand Biologic Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 87. Thailand Biologic Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 88. Malaysia Biologic Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 89. Malaysia Biologic Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 90. Philippines Biologic Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 91. Philippines Biologic Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 92. Vietnam Biologic Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 93. Vietnam Biologic Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 94. Latin America Biologic Drugs Sales Growth Rate 2015-2020 (K Units)
Figure 95. Latin America Biologic Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 96. Latin America Biologic Drugs Sales Market Share by Country in 2019
Figure 97. Latin America Biologic Drugs Revenue Market Share by Country in 2019
Figure 98. Mexico Biologic Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 99. Mexico Biologic Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 100. Brazil Biologic Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 101. Brazil Biologic Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 102. Argentina Biologic Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 103. Argentina Biologic Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 104. Middle East and Africa Biologic Drugs Sales Growth Rate 2015-2020 (K Units)
Figure 105. Middle East and Africa Biologic Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 106. Middle East and Africa Biologic Drugs Sales Market Share by Country in 2019
Figure 107. Middle East and Africa Biologic Drugs Revenue Market Share by Country in 2019
Figure 108. Turkey Biologic Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 109. Turkey Biologic Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 110. Saudi Arabia Biologic Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 111. Saudi Arabia Biologic Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 112. U.A.E Biologic Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 113. U.A.E Biologic Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 114. Porter's Five Forces Analysis
Figure 115. Biologic Drugs Value Chain
Figure 116. Channels of Distribution
Figure 117. Distributors Profiles
Figure 118. Bottom-up and Top-down Approaches for This Report
Figure 119. Data Triangulation
Figure 120. Key Executives Interviewed

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Antioxidant Vitamins Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 100

The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......

Global Clavulanate Potassium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86

The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030. North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......

Global Amoxicillin Sodium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 84

The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030. North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......

Global Melatonin Supplements Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106

The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......

Global Sleeping Pills (Prescription Drugs) Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93

The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......

Global Sleeping Pills Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94

The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......

Global Zinc Oral Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......

Global Zinc Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......

Global Anti-Infectives Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78

The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs